138 related articles for article (PubMed ID: 34535406)
1. Evaluation of renal effects of liposomal amphotericin B in children with malignancies with KDIGO and RIFLE criteria.
Devrim F; Çağlar İ; Acar SO; Akkuş Ş; Dinçel N; Yılmaz E; Tahta N; Demirağ B; Karapınar TH; Gözmen S; Oymak Y; Vergin C; Bayram N; Devrim İ
Nephrol Ther; 2021 Dec; 17(7):507-511. PubMed ID: 34535406
[TBL] [Abstract][Full Text] [Related]
2. Retrospective Cohort Analysis of Liposomal Amphotericin B Nephrotoxicity in Patients with Hematological Malignancies.
Stanzani M; Vianelli N; Cavo M; Maritati A; Morotti M; Lewis RE
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28607011
[TBL] [Abstract][Full Text] [Related]
3. Association between potassium supplementation and the occurrence of acute kidney injury in patients with hypokalemia administered liposomal amphotericin B: a nationwide observational study.
Ota Y; Obata Y; Takazono T; Tashiro M; Wakamura T; Takahashi A; Shiozawa Y; Miyazaki T; Nishino T; Izumikawa K
BMC Nephrol; 2021 Jun; 22(1):240. PubMed ID: 34193064
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Hypokalemia as a Side Effect of Liposomal Amphotericin in Pediatric Patients.
Kobayashi R; Keino D; Hori D; Sano H; Suzuki D; Kishimoto K; Kobayashi K
Pediatr Infect Dis J; 2018 May; 37(5):447-450. PubMed ID: 28945677
[TBL] [Abstract][Full Text] [Related]
5. Comparison of nephrotoxicity associated to different lipid formulations of amphotericin B: a real-life study.
Falci DR; da Rosa FB; Pasqualotto AC
Mycoses; 2015 Feb; 58(2):104-12. PubMed ID: 25590436
[TBL] [Abstract][Full Text] [Related]
6. Adverse effects of amphotericin B in children; a retrospective comparison of conventional and liposomal formulations.
Andrew EC; Curtis N; Coghlan B; Cranswick N; Gwee A
Br J Clin Pharmacol; 2018 May; 84(5):1006-1012. PubMed ID: 29352486
[TBL] [Abstract][Full Text] [Related]
7. The evaluation of frequency of nephrotoxicity caused by liposomal amphotericin B.
Kato H; Hagihara M; Yamagishi Y; Shibata Y; Kato Y; Furui T; Watanabe H; Asai N; Koizumi Y; Mikamo H
J Infect Chemother; 2018 Sep; 24(9):725-728. PubMed ID: 29773439
[TBL] [Abstract][Full Text] [Related]
8. Potential Usefulness of Early Potassium Supplementation for Preventing Severe Hypokalemia Induced by Liposomal Amphotericin B in Hematologic Patients: A Retrospective Study.
Okada N; Azuma M; Imanishi M; Zamami Y; Kirino Y; Nakamura T; Teraoka K; Abe M; Ishizawa K
Clin Ther; 2018 Feb; 40(2):252-260. PubMed ID: 29305017
[TBL] [Abstract][Full Text] [Related]
9. Factor analysis of acute kidney injury in patients administered liposomal amphotericin B in a real-world clinical setting in Japan.
Takazono T; Tashiro M; Ota Y; Obata Y; Wakamura T; Miyazaki T; Nishino T; Izumikawa K
Sci Rep; 2020 Sep; 10(1):15033. PubMed ID: 32929112
[TBL] [Abstract][Full Text] [Related]
10. Risk factors of amphotericin B toxicty in the nonneonatal pediatric population.
Dutta A; Palazzi DL
Pediatr Infect Dis J; 2012 Sep; 31(9):910-4. PubMed ID: 22581225
[TBL] [Abstract][Full Text] [Related]
11. Impact of liposomal amphotericin B on renal function in critically ill patients with renal function impairment.
Alvarez-Lerma F; Soriano MC; Rodríguez M; Catalán M; Llorente AM; Vidart N; Garitacelaya M; Maraví E; Fernández E; Alvarado F; López M; Alvarez-Sánchez B; Espinosa J; Quintana E;
Rev Esp Quimioter; 2012 Sep; 25(3):206-15. PubMed ID: 22987267
[TBL] [Abstract][Full Text] [Related]
12. Prospective phase II single-center study of the safety of a single very high dose of liposomal amphotericin B for antifungal prophylaxis in patients with acute myeloid leukemia.
Annino L; Chierichini A; Anaclerico B; Finolezzi E; Norata M; Cortese S; Cassetta MI; Fallani S; Novelli A; Girmenia C
Antimicrob Agents Chemother; 2013 Jun; 57(6):2596-602. PubMed ID: 23529741
[TBL] [Abstract][Full Text] [Related]
13. Incidence, Predictors, and Impact on Hospital Mortality of Amphotericin B Nephrotoxicity Defined Using Newer Acute Kidney Injury Diagnostic Criteria.
Rocha PN; Kobayashi CD; de Carvalho Almeida L; de Oliveira Dos Reis C; Santos BM; Glesby MJ
Antimicrob Agents Chemother; 2015 Aug; 59(8):4759-69. PubMed ID: 26014956
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Low-Dose Liposomal Amphotericin B in Adult Patients Undergoing Unrelated Cord Blood Transplantation.
Yasu T; Konuma T; Oiwa-Monna M; Kato S; Tanoue S; Isobe M; Mizusawa M; Kuroda S; Takahashi S; Tojo A
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30104271
[TBL] [Abstract][Full Text] [Related]
15. Occurrence and improvement of renal dysfunction and serum potassium abnormality during administration of liposomal amphotericin B in patients with hematological disorders: A retrospective analysis.
Yamazaki H; Kondo T; Aoki K; Yamashita K; Takaori-Kondo A
Diagn Microbiol Infect Dis; 2018 Feb; 90(2):123-131. PubMed ID: 29203252
[TBL] [Abstract][Full Text] [Related]
16. Role of urine neutrophil gelatinase-associated lipocalin in the early diagnosis of amphotericin B-induced acute kidney injury.
Rocha PN; Macedo MN; Kobayashi CD; Moreno L; Guimarães LH; Machado PR; Badaró R; Carvalho EM; Glesby MJ
Antimicrob Agents Chemother; 2015 Nov; 59(11):6913-21. PubMed ID: 26303800
[TBL] [Abstract][Full Text] [Related]
17. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients.
Prentice HG; Hann IM; Herbrecht R; Aoun M; Kvaloy S; Catovsky D; Pinkerton CR; Schey SA; Jacobs F; Oakhill A; Stevens RF; Darbyshire PJ; Gibson BE
Br J Haematol; 1997 Sep; 98(3):711-8. PubMed ID: 9332329
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Amphotericin B Lipid Formulations for Treatment of Severe Coccidioidomycosis.
Sidhu R; Lash DB; Heidari A; Natarajan P; Johnson RH
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29686150
[TBL] [Abstract][Full Text] [Related]
19. Conventional Amphotericin B Associated Nephrotoxicity in Patients With Hematologic Malignancies.
Gursoy V; Ozkalemkas F; Ozkocaman V; Serenli Yegen Z; Ethem Pinar I; Ener B; Akalın H; Kazak E; Ali R; Ersoy A
Cureus; 2021 Jul; 13(7):e16445. PubMed ID: 34422476
[TBL] [Abstract][Full Text] [Related]
20. Low-dose amphotericin B lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies--a randomized, controlled trial.
Subirà M; Martino R; Gómez L; Martí JM; Estany C; Sierra J
Eur J Haematol; 2004 May; 72(5):342-7. PubMed ID: 15059069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
